Dow Up 0.93% Nasdaq Up 0.06%

Incyte Corporation (INCY)

-NasdaqGS
63.69 Up 5.82(10.06%) 12:36PM EDT - Nasdaq Real Time Price
Prev Close:57.87
Open:59.02
Bid:63.76 x 100
Ask:63.85 x 100
1y Target Est:75.15
Beta:-0.13
Next Earnings Date:30-Oct-14INCY Earnings announcement
Day's Range:59.02 - 64.88
52wk Range:35.21 - 70.86
Volume:1,204,208
Avg Vol (3m):975,566
Market Cap:10.73B
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYUp 10.06%10.73B
AMGNUp 1.02%122.14B
CELGUp 1.72%85.51B
RHHBYUp 1.17%252.50B

Key Statistics

Forward P/E (1 yr):255.12
P/S (ttm):26.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.39
Quarterly EPS Est (Sep-14) :0.00
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback